Clinical trial
Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)
NCT00257647 · Hadassah Medical Organization, Other · Completed
Key facts
| NCT number | NCT00257647 |
|---|---|
| Title | Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML) |
| Official title | Use of SV40 siRNA Vectors to Treat CML |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | United States Department of Defense U.S. Fed |
| Status | Completed |
| Study type | Observational |
| Conditions | Chronic Myeloid Leukemia |
| Intervention type | Other |
| Interventions | SV40 vectors carrying siRNA |
| Enrollment | 25 |
| Start date | Sep 1, 2005 |
| Completion | Nov 1, 2007 |
| First posted | Nov 23, 2005 |
| Last update posted | Feb 18, 2009 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: